International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Left Ventricular Dysfunction Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 1200 participants.

Also called NCT06566183

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06566183
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Brazil, India, Mexico, Poland, South Korea (from the registry)
Registry status
  • Suspended (from the registry)

Technical summary

Registry record NCT06566183. Randomized; no masking; primary purpose treatment. Start 2026-12 (anticipated); primary completion 2030-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Left Ventricular Dysfunction Trial
Acronym
ISCHEMIA-LVD
Condition
Cognitive Impairment
Condition
Heart Failure
Intervention (Procedure)
Guideline-directed medical therapy (GDMT)
Lead sponsor
NYU Langone Health (class: other)

Record details

Record id
cardio:ct-nct06566183
Content hash
e8bf342d5f87a3692f5145dad8f802805952b059d04da342f2faf7dcc854a649